覆盖概率计划在局部晚期宫颈癌淋巴结补量中的临床实施
该研究在局部晚期宫颈癌(LACC)中实施覆盖概率(CovP)用于病理淋巴结同步整合补量(SIB)的剂量计划。对25例既往治疗患者的47枚补量淋巴结分析显示,CovP约束可行,且相比全PTV-N覆盖计划,显著降低体部、骨盆骨和肠道的V50(p<0.001)。
要点
- CovP约束:PTV-N D98>90%、CTV-N D98>100%、CTV-N D50>101.5%处方剂量。
- 89%淋巴结在CBCT可见,外照射期间呈同心退缩。
- CovP相比全PTV-N覆盖显著降低体部、骨骼和肠道V50(p<0.001)。
核心结论
- CovP用于病理淋巴结SIB在临床可行,并显著降低邻近OAR的SIB collateral剂量。
研究设计与样本
- 为Eclipse治疗计划系统生成CovP约束,用于病理淋巴结靶区(PTV-N)SIB计划。
- 分析25例既往治疗患者的47枚补量淋巴结,淋巴结在CBCT上勾画并计算累积剂量。
主要发现
- 89%淋巴结在CBCT可见,外照射期间呈明显同心退缩。
- 98%可见淋巴结的总EBRT和BT D98>57 GyEQD2。
- 相比全PTV-N覆盖计划,CovP显著降低体部、骨盆骨和肠道的V50(p<0.001)。
关键数值与推荐
- PTV-N D98>90%处方剂量。
- CTV-N D98>100%处方剂量。
- CTV-N D50>101.5%处方剂量。
- EBRT剂量45Gy/25次,SIB 55-57.5Gy取决于BT预期剂量。
临床怎么用
- 对LACC病理淋巴结SIB可采用CovP约束以降低OAR剂量。
- 需在CBCT上勾画淋巴结并评估累积剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To implement coverage probability (CovP) for dose planning of simultaneous integrated boost (SIB) of pathologic lymph nodes in locally advanced cervical cancer (LACC). MATERIAL AND METHODS: CovP constraints for SIB of the pathological nodal target (PTV-N) with a central dose peak and a relaxed coverage at the perimeter were generated for use with the treatment planning system Eclipse: PTV-N D98 >90%, CTV-N D98 >100% and CTV-N D50 >101.5% of prescribed dose. Dose of EBRT was 45Gy/25 fx with a SIB of 55-57.5Gy depending on expected dose from brachytherapy (BT). Twenty-five previously treated patients with 47 boosted nodes were analysed. Nodes were contoured on cone beam CT (CBCT) and the accumulated dose in GTV-NCBCT and volume of body, pelvic bones and bowel receiving >50Gy (V50) were determined. RESULTS: Nearly all nodes (89%) were visible on CBCT and showed considerable concentric regression during EBRT. Total EBRT and BT D98 was >57 GyEQD2 in 98% of the visible nodes. Compared to treatment plans aiming for full PTV-N coverage, CovP significantly reduced V50 of body, bones and bowel (p<0.001) CONCLUSION: CovP is clinically feasible for SIB of pathological nodes and significantly decreases collateral SIB dose to nearby OAR.
引用
- Ramlov A, Assenholt MS, Jensen MF, et al. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiother Oncol. 2017. PMID: 28190601. doi:10.1016/j.radonc.2017.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。